Wanbury Limited has informed the Exchange regarding a press release dated August 13, 2026, titled "Press Release regarding EDQM Approval for new product Rivaroxaban API,USFDA DMF Clearances".
Wanbury Limited Press Release Aug 13 2026
Earlier from Wanbury
- Wanbury Limited Press Release Aug 11 2026
- Wanbury Limited Press Release Jul 30 2026
- Wanbury Limited Press Release Jun 25 2026
- Wanbury Limited Press Release Jun 10 2026
